+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Glaucoma - Pipeline Insight, 2025 - Product Thumbnail Image

Glaucoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
Ocular Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular Hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Primary Sclerosing Cholangitis - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Argininosuccinic Aciduria - Pipeline Insight, 2025 - Product Thumbnail Image

Argininosuccinic Aciduria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Renal Tubular Acidosis (RTA) - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Tubular Acidosis (RTA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Still's Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Still's Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tuberous Sclerosis- Pipeline Insight, 2025 - Product Thumbnail Image

Tuberous Sclerosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mydriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Mydriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Osteonecrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Osteonecrosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hemochromatosis- Pipeline Insight, 2025 - Product Thumbnail Image

Hemochromatosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
SMO Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

SMO Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Optic Neuritis - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Optic Neuritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Exportin-1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Exportin-1 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatitis C Virus Infection- Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis C Virus Infection- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Gaucher's Disease Type I - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease Type I - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gaucher's Disease Type III - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease Type III - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Vancomycin Resistant Enterococcal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Vancomycin Resistant Enterococcal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Norovirus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Norovirus Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Klebsiella Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Klebsiella Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more